The genetic polymorphisms of PAI-1 are linked to lower PAI-1 plasma levels and are associated with increased risk of developing MS syndrome [125,126]. Here, SERPINE1 is linked to multiple congenital anomalies-hypotonia-seizures syndrome 3.